Uri Weinberg - 10 May 2021 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Chief Science Officer
Signature: By: /s/ Steven Robbins, Attorney in Fact for Uri Weinberg
Issuer symbol: NVCR
Transactions as of: 10 May 2021
Net transactions value: -$888,607
Form type: 4
Filing time: 12 May 2021, 16:13:45 UTC
Next filing: 08 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Options Exercise	$182,916	+3,846	+11%	$47.56	37,317	10 May 2021	Direct
transaction	NVCR	Ordinary Shares	Sale	$729,394	-3,846	-10%	$189.65^*	33,471	10 May 2021	Direct	F1
transaction	NVCR	Ordinary Shares	Sale	$342,129	-1,804	-5.4%	$189.65^*	31,667	10 May 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVCR	Options to Buy Ordinary Shares	Options Exercise	$0	-3,846	-50%	$0.000000	3,845	10 May 2021	Ordinary Shares	3,846	$47.56	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg.
F2	Fully vested as of the date hereof.